• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Gastroenterology

Prophylactic probiotic use trends toward decreased incidence of nosocomial infections in preterm infants

bys25qthea
October 21, 2012
in Gastroenterology, Infectious Disease, Pediatrics
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD/CDC

Key study points:

1. Administration of L reuteri to preterm infants was not significantly associated with a reduction in rates of nosocomial infection or death, when compared to placebo; however, there was a trend towards lower rates of pneumonia and necrotizing enterocolitis (NEC) in the probiotic group.

2. L reuteri prophylaxis was associated with decrease in length of hospitalization and episodes of feeding intolerance among infants weighing less than 1500 grams.

Primer: Among many other complications, preterm infants face an increased risk of nosocomial infection and necrotizing NEC due to their immature immune responses and mucosal barriers to invasion. The pathogenesis underlying NEC is not fully understood; however, it is thought bacterial invasion likely plays a role. There has been recent interest in using probiotics (supplements or foods containing beneficial bacterial flora) to protect against pathogenic bacterial invasion of the gastrointestinal (GI) tract. It is believed that probiotics directly compete with attachment of pathogenic organisms to the GI tract and may up-regulate the neonatal immune response against NEC-associated bacteria. The current study aims to determine if the use of prophylactic Lactobacillus reuteri, a naturally occurring human intestinal bacterium, reduces nosocomial infection-associated morbidity and mortality among pre-term infants.

Background reading:

RELATED REPORTS

Less social media usage is associated with improved internalizing symptoms in high-risk young adults.

AI cardiac MRI analysis marginally outperforms clinicians in predicting all-cause mortality

1. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20, randomized controlled trials [Journal of Pediatric Surgery]

2. Probiotics for the prevention of necrotizing enterocolitis in preterm infants (Review) [The Cochrane Collaboration]

3. Lactoferrin for prevention of neonatal infections [Current Opinion in Infectious Disease]

This [double-blinded, randomized, placebo-controlled] study included data from 9 neonatal intensive care units (NICUs) in Colombia from 2008-2011 and is the largest study examining probiotic use in this population. 750 hemodynamically stable preterm infants weighing less than 2000g, less than 2 days old, and admitted to the NICU, were randomized to receive either L reuteri (n = 372) or placebo prophylaxis (n = 380). Primary outcomes included death and nosocomial infection, as indicated by positive blood, urine, or CSF cultures, or evidence of nosocomial pneumonia, NEC, or feeding intolerance.

There was no significant difference in rates of death, nosocomial bloodstream, urinary tract, or CNS infection, pneumonia, or NEC between the group receiving probiotics and the group receiving placebo. Infants weighing less than 1500g and receiving L reuteri experienced significantly fewer episodes of feeding intolerance (9.6% vs. 16.8%, p = .04) and were hospitalized for a significantly shorter time (32 days vs. 37 days, p = .03) than those assigned to the placebo group. Although not statistically significant, there was a 40% decrease in NEC and a trend towards lower rates of pneumonia among those receiving probiotic treatment compared to placebo.

In sum: While the use of L reuteri prophylaxis in the current study was not significantly associated with a decrease in morbidity or mortality secondary to nosocomial infection in preterm infants, there was a trend towards lower rates of pneumonia and necrotizing enterocolitis (NEC) in the probiotic group. A low primary outcome rate (given improved NICU infection control mechanisms) may have underpowered the study, and the possibility of inadequate gut colonization using the current probiotic dosing may have contributed to these insignificant findings. The fact that probiotic administration was associated with fewer episodes of feeding difficulty and decreased lengths of hospital stay among smaller infants implies some benefit from L reuteri use; however, causation cannot be established from the current study. Additional, adequately powered studies should be completed to better define the potential impact of probiotic use. The researchers conclude that their study is consistent with other meta-analyses looking at the beneficial effects of probiotic prophylaxis in preterm infants.

Click to read the study in Pediatrics

By [LHC] and [DB]

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCLAIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

Previous Post

Live births from Assisted Reproductive Technologies increasing in recent years

Next Post

Opiate substitution treatment associated with reduced risk of HIV transmission among injection drug users

RelatedReports

Teen smartphone use collage: a teenage boy in a hoodie looking down at a phone, with empty speech bubbles rising from it
All Specialties

Less social media usage is associated with improved internalizing symptoms in high-risk young adults.

November 19, 2026
Physical activity collage: an engraved bicycle, a water bottle lying on its side and a path of flat stepping stones
Artificial Intelligence

AI cardiac MRI analysis marginally outperforms clinicians in predicting all-cause mortality

November 19, 2026
An abstract representation featuring a syringe, pills, a silhouette of a person, and molecular structures, suggesting themes related to obesity treatment.
All Specialties

In a phase 3 trial, tirzepatide reduced BMI versus placebo in adolescents with obesity and obesity-related complications

November 19, 2026
Lung cancer immunotherapy collage: engraved lungs and trachea, a cluster of round immune cells and a folded surgical towel
Cardiology

Continuation of immunotherapy after immune checkpoint inhibitor-induced myocarditis in patients with lung cancer may be safe and effective

November 19, 2026
Next Post

Opiate substitution treatment associated with reduced risk of HIV transmission among injection drug users

HPV vaccination not associated with increase in sexual activity-related outcomes amongst 11 and 12 year-old females

Multivitamin use decreases total cancer risk among older men

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Less social media usage is associated with improved internalizing symptoms in high-risk young adults.
  • AI cardiac MRI analysis marginally outperforms clinicians in predicting all-cause mortality
  • In a phase 3 trial, tirzepatide reduced BMI versus placebo in adolescents with obesity and obesity-related complications
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.